Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
Hoosier Cancer Research Network
M.D. Anderson Cancer Center
Neonc Technologies, Inc.
Black Diamond Therapeutics, Inc.
Wayshine Biopharm, Inc.
Servier
M.D. Anderson Cancer Center
Massachusetts General Hospital
Yuhan Corporation
National Cancer Institute (NCI)
Cambridge University Hospitals NHS Foundation Trust
First People's Hospital of Hangzhou
Stanford University
BBB-Therapeutics B.V.
Betta Pharmaceuticals Co., Ltd.
Novartis